Document Type

Patent

Publication Date

2-23-2016

Patent Number

9265783

CPC

A61K 31/7076 (20130101)

Abstract

This application relates to combination therapies including triciribine compounds and epidermal growth factor receptor inhibitor compounds, particularly erlotinib-like compounds and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.

Application Number

14/092,323

Assignees

University of South Florida

Filing Date

2013-11-27

Share

COinS